8-K: Cigna Group Reports Strong 2023 Results, Raises 2024 Outlook and Increases Dividend

The Cigna Group announced strong fourth quarter and full year 2023 results, increased its 2024 adjusted EPS outlook, and raised its quarterly dividend by 14%.

Summary

• The Cigna Group reported total revenues of $195.3 billion for 2023.
• Shareholders net income for 2023 was $5.2 billion, or $17.39 per share.
• Adjusted income from operations for 2023 was $7.4 billion, or $25.09 per share.
• The company projects 2024 adjusted income from operations to be at least $8.025 billion, or at least $28.25 per share.
• The Board of Directors has declared a 14% increase in the quarterly dividend to $1.40 per share.
• Fourth quarter 2023 shareholders net income was $1.0 billion, or $3.49 per share, which includes a net after-tax loss of $552 million, or $1.88 per share, primarily due to the loss on sale of businesses and other charges.
• Adjusted income from operations for the fourth quarter of 2023 was $2.0 billion, or $6.79 per share.
• Total pharmacy customers increased by 5% to 98.6 million, and total medical customers grew by 10% to 19.8 million in 2023.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, increased dividend, and positive future outlook. However, there are some negative aspects such as the loss on sale of businesses and increased expenses, which temper the overall sentiment.

Positives

• The company experienced strong revenue and earnings growth across its diversified portfolio.
• There was a significant increase in adjusted income from operations in the fourth quarter of 2023.
• The company saw growth in both pharmacy and medical customer numbers.
• The medical care ratio improved in both the fourth quarter and full year 2023.
• The company has increased its dividend by 14%.

Negatives

• Shareholders net income for the fourth quarter of 2023 was negatively impacted by a net after-tax loss of $552 million, primarily due to the loss on sale of businesses and other charges.
• Shareholders net income for 2023 was lower than in 2022.
• The SG&A expense ratio increased in the fourth quarter of 2023 due to a one-time cost of an organizational efficiency plan.
• The company experienced a loss in the Corporate and Other Operations segment.

Risks

• The company's future results may differ materially from its current estimates due to various factors.
• The company faces risks related to competition, changes in the industry, and regulatory changes.
• There are risks associated with the company's multinational operations, including currency exchange rates.
• The company is exposed to potential cyberattacks and data security incidents.
• The company's performance is subject to economic and market conditions, including the risk of a recession.

Future Outlook

The Cigna Group projects at least $235 billion in adjusted revenues and at least $8.025 billion in adjusted income from operations, or at least $28.25 per share, for full year 2024. This outlook includes the impact of expected future share repurchases and anticipated 2024 dividends.

Management Comments

• David M. Cordani, chairman and CEO of The Cigna Group, stated that 2023 was another very strong year for the company with consistent execution and sustained growth.
• He also mentioned that they will accelerate their momentum in 2024, leading in improving value, affordability, and clinical outcomes, as well as expanding access and choice.

Industry Context

This announcement reflects the ongoing trends in the healthcare industry, including a focus on value-based care, affordability, and digital health solutions. The growth in both pharmacy and medical customers indicates a strong market position for Cigna in a competitive landscape.

Comparison to Industry Standards

• Cigna's adjusted income from operations of $7.4 billion for 2023 is a strong result compared to other large health insurers such as UnitedHealth Group and Humana, although direct comparisons are difficult without detailed segment breakdowns.
• The 14% increase in the quarterly dividend is a positive signal for investors and is in line with the trend of returning value to shareholders in the healthcare sector.
• The medical care ratio of 81.3% for the full year 2023 is competitive with industry benchmarks, indicating effective cost management.
• The projected adjusted income from operations of at least $8.025 billion for 2024 suggests continued growth and is a positive outlook compared to some competitors who are facing headwinds in the current economic environment.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and positive financial results.
• Customers will benefit from the company's focus on improving value, affordability, and clinical outcomes.
• Employees may be impacted by the organizational efficiency plan.
• The company's strong performance may positively impact suppliers and other business partners.

Next Steps

• The company will continue to focus on improving value, affordability, and clinical outcomes.
• The company will expand access and choice for its customers.
• The company will host a conference call to review the full year 2023 results and discuss the full year 2024 outlook.

Key Dates

Keywords

Cigna Group, Healthcare, Financial Results, Earnings, Dividend, Adjusted Income, Revenue, Medical Customers, Pharmacy Customers, Evernorth Health Services